Clinical Impact.
Back to lobbyMarch 28, 2024
Automated digital morphometry of peripheral blood smears detects both infrequent events and cellular population patterns in myelodysplastic syndrome
Objective:
Current diagnosis of myelodysplastic syndrome (MDS) is based on invasive bone marrow aspirate, followed by subjective morphological analysis. The novel Full-Field Morphology (FFM) technology developed by Scopio Labs performs peripheral blood smear (PBS) analysis on a large scale of 1000 fields of 100X view in a routine manner, allowing a precise and highly sensitive automated quantification of cellular and sub-cellular morphological parameters. In this study, we applied this digital morphometric approach to compare PBS morphology of MDS patients with age-matched controls.
Conclusion:
Our study demonstrates that FFM-based digital PBS analysis enables the detection and quantification of unique WBC and RBC morphologic alterations associated with MDS.